Kellie Meyer, PharmD, MPH, is VP of Evidence Generation & Value Communications for Biopharma Services. She leads a team focused on health economics within Biopharma Services Evidence Synthesis and Modeling practice. 

 

Dr. Meyer’s team guides manufacturer clients through Global Health Economics and Outcomes Research (GHEOR) engagements including economic modeling, global market access strategy, comparative effectiveness research, outcomes analyzers, quality improvement programs, dossiers, and scientific publications.

Dr. Meyer has a wide range of expertise in developing value propositions and gathering payer insights to inform market access and GHEOR initiatives. Her experience ranges across several disease areas including neurology, mental health, hematology, infectious disease, cardiology, anesthesiology, rare/orphan diseases, and oncology. Her work has appeared in a variety of scientific publications including Journal of Managed Care Pharmacy, Journal of Medical Economics, Current Medical Research and Opinion, Journal of Clinical Gastroenterology, among others.

Dr. Meyer earned her Doctor of Pharmacy degree from the Northeastern University Bouvé College of Health Sciences School of Pharmacy. Her post-doctoral training includes a pharmacy practice residency at The Johns Hopkins Hospital and an outcomes research fellowship at Xcenda. She also received a Master of Public Health degree in Epidemiology from the University of South Florida College of Public Health.